Gliomas more often than other G-/GM-CSF-secreting cancers also express intratumoral cognate receptors; augmented G-/GM-CSF(R) levels have been found to correlate with higher tumor grade 34–36. This evidence concerns the gene CSF2 and central nervous system cancer.